Study Group: Velcade Prescribers for CML (US)

Council Members in this Study Group: 93

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

William Matsui

Associate Professor
Johns Hopkins University - CC

William Matsui, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center and the Johns Hopkins School of Medicine in Maryland, since July 2008. Dr. Matsui specializes in clinical and laboratory examination of hematological...

Donald Fleming

Director of the Cancer Care Center
DAVIS HEALTH SYSTEM, INC.

Donald Fleming, MD, is presently the Director of the Cancer Care Center for the Davis Health System. He was the Head of Hematology-Oncology at the Medical Center of Vincennes until mid 2008. Previously, Dr. Fleming was a Tenured Professor in the Division...

Eric Jacobsen

Instructor in Medicine
DANA-FARBER CANCER INSTITUTE, INC.

Eric Jacobsen, MD, is Medical Oncologist and Hematologist in the Hematology and Oncology Department at the Dana-Farber Cancer Institute in Boston, MA. Dr. Jacobsen is a member of the lymphoma and bone marrow transplant divisions at Dana-Farber Cancer...

Donald Tsai

Associate Professor of Medicine
University of Pennsylvania Cancer Center

Donald Tsai, MD, PhD, is an Associate Professor of Medicine at the University of Pennsylvania Cancer Center. Dr. Tsai specializes in the treatment of hematological malignancies such as leukemia, multiple myeloma, lymphoma, Hodgkin's disease, myelodysplastic...

Taral Patel

Oncologist
MID-OHIO ONCOLOGY & HEMOTOLOGY INC

Taral Patel, MD, is Oncologist in private practice with Mid-Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been Principal Investigator for multiple clinical trials in colon cancer, lung cancer, lymphoma,...

View all Leading Experts in this Study Group

Join this Study Group

Members in this Study Group include these company types:

Academic Medical Center/Hospital or Clinic
Office Based Private Practice or Clinic
Non-Academic Community Hospital or Clinic
Academic Institution*

Members in this Study Group often have these job titles:

Physician - Attending Physician
Physician - Director
Physician - Division Head
Director
Professor

Related Study Groups

Study Group Name	No. Members
VELCADE (Bortezomib)	38
Aranesp Prescribers for Red Blood Cell Disorders (US)	56
Oncology Reimbursement Experts (US)	182
Users of BRACAnalysis Testing for Breast and Ovarian Cancer (US)	131
Physicians who Treat Hemophilia (US)	49
Biostatisticians (US)	254
Immunologists (US)	378
ONC-Avastin Prescribers for Colorectal Cancer (US)	55

GLG Live Meetings with this Study Group's Leading Experts (?)

December 2, 2009 | Boston

Seminar: Hot Topics at the Upcoming 51st Annual American Society of Hematology Meeting (Boston)

November 28, 2007 | New York

GLGi: Hematology Grand Rounds

GLG Webcasts & Teleconferences

Leading Experts in Velcade Prescribers for CML (US) have not participated in any GLG webcasts.

View All GLG Webcasts & Teleconferences in Healthcare